Hepa 1-6

Export PDF

Strain Information

Cell Line

Hepa 1-6

Cat. NO.

NM-GA02

Model Description

The Hepa1-6 cell line is a derivative of the BW7756 mouse hepatoma that arose in a C57/L mouse.

Strain State

Validation of tumorigenic capacity completed

Validation Data

I. Characterization of in vivo growth kinetics

The Hepa1-6 cells were subcutaneously inoculated into the C57BL/6 mice.

image.png

Figure 1. Tumor growth curve of Hepa1-6 allogeneic model (n=6)

image.png

Figure 2. Body weight change of Hepa1-6 allogeneic model (n=6)

*Wild-type cell lines are not for sale, and only applled to construction of tumor bearing mice and in-vivo efficacy studies.

Related Strain(s)

CT26-hPD-L1/hCLAUDIN 18.2
Cell Line：

CT26-hPD-L1/hCLAUDIN 18.2

Cat. NO.：NMC-230112
CT26-hDLL3
Cell Line：

CT26-hDLL3

Cat. NO.：NMC-230087
CT26-hCLDN 18.2 (2)
Cell Line：
Cat. NO.：NMC-230109
HCC1569
Cell Line：

HCC1569

Cat. NO.：NM-R19
NCI-H716
Cell Line：

NCI-H716

Cat. NO.：NM-J16

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more